Literature DB >> 21963516

Genomic risk of hepatitis C-related hepatocellular carcinoma.

Yujin Hoshida1, Bryan C Fuchs, Kenneth K Tanabe.   

Abstract

To identify the genetic susceptibility factor(s) for hepatitis C virus-induced hepatocellular carcinoma (HCV-induced HCC), we conducted a genome-wide association study using 432,703 autosomal SNPs in 721 individuals with HCV-induced HCC (cases) and 2890 HCV-negative controls of Japanese origin. Eight SNPs that showed possible association (P <1 10(⁻5)) in the genome-wide association study were further genotyped in 673 cases and 2596 controls. We found a previously unidentified locus in the 50 flanking region of MICA on 6p21.33 (rs2596542, P(combined) = 4.21 10(⁻13), odds ratio = 1.39) to be strongly associated with HCV induced HCC. Subsequent analyses using individuals with chronic hepatitis C (CHC) indicated that this SNP is not associated with CHC susceptibility (P = 0.61) but is significantly associated with progression from CHC to HCC (P = 3.13 10(⁻8)). We also found that the risk allele of rs2596542 was associated with lower soluble MICA protein levels in individuals with HCV-induced HCC (P = 1.38 10(⁻13)).

Entities:  

Year:  2011        PMID: 21963516     DOI: 10.1016/j.jhep.2011.08.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  9 in total

Review 1.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

Review 2.  Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.

Authors:  Yujin Hoshida; Bryan C Fuchs; Nabeel Bardeesy; Thomas F Baumert; Raymond T Chung
Journal:  J Hepatol       Date:  2014-11-03       Impact factor: 25.083

Review 3.  Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies?

Authors:  Ivan Rusyn; Stanley M Lemon
Journal:  Cancer Lett       Date:  2013-07-18       Impact factor: 8.679

Review 4.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

5.  Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma.

Authors:  Hongguang Li; Fangfeng Liu; Huaqiang Zhu; Xu Zhou; Jun Lu; Hong Chang; Jinhua Hu
Journal:  Med Sci Monit       Date:  2016-02-19

6.  DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection.

Authors:  Maria Antonella Burza; Benedetta Maria Motta; Rosellina Margherita Mancina; Piero Pingitore; Carlo Pirazzi; Saverio Massimo Lepore; Rocco Spagnuolo; Patrizia Doldo; Cristina Russo; Veronica Lazzaro; Janett Fischer; Thomas Berg; Alessio Aghemo; Cristina Cheroni; Raffaele De Francesco; Silvia Fargion; Massimo Colombo; Christian Datz; Felix Stickel; Luca Valenti; Stefano Romeo
Journal:  Hepatology       Date:  2015-12-18       Impact factor: 17.425

7.  Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases.

Authors:  Amal A Mohamed; Ola M Elsaid; Eman A Amer; Heba H Elosaily; Mohamed I Sleem; Shawkat S Gerges; Mohamed A Saleh; Amal El Shimy; Yasmine S El Abd
Journal:  J Adv Res       Date:  2017-03-18       Impact factor: 10.479

8.  Next-generation sequencing: application in liver cancer-past, present and future?

Authors:  Jens U Marquardt; Jesper B Andersen
Journal:  Biology (Basel)       Date:  2012-08-31

Review 9.  Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma.

Authors:  Ranran Tang; Heng Liu; Yingdi Yuan; Kaipeng Xie; Pengfei Xu; Xiaoyun Liu; Juan Wen
Journal:  Oncotarget       Date:  2017-05-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.